The Role of Percentage of Prostate-specific Antigen Reduction After Focal Therapy Using High-intensity Focused Ultrasound for Primary Localised Prostate Cancer. Results from a Large Multi-institutional Series.
Sign Up to like & getrecommendations! Published in 2020 at "European urology"
DOI: 10.1016/j.eururo.2020.04.068
Abstract: Focal therapy (FT) for prostate cancer (PCa) is emerging as a novel therapeutic approach for patients with low- to intermediate-risk disease, in order to provide acceptable oncological control, whilst avoiding the side effects of radical… read more here.
Keywords: prostate; reduction; treatment; focal therapy ... See more keywords
6 Years of experience with abiraterone acetate at SAMS day care hospital
Sign Up to like & getrecommendations! Published in 2019 at "Annals of Medicine"
DOI: 10.1080/07853890.2018.1561720
Abstract: Introduction: The reduction of PSA is one of the effects of abiraterone acetate [1] and it is considered one indicator of therapy success. It has been increasingly used in early stages of prostate cancer metastatic… read more here.
Keywords: reduction; abiraterone acetate; treatment; psa reduction ... See more keywords